Approximately 15% of people with Parkinson’s disease have a close relative who also has or had the condition, suggesting that genetics may play a role in its development. Although most cases of Parkinson’s are considered sporadic - arising without a clear familial link - research has revealed that certain genetic mutations can increase the risk of developing the disease, particularly in cases of early-onset Parkinson’s, which appears before the age of 40.

​

Genetic Mutations Linked to Parkinson’s Disease

Scientists have identified several key genetic mutations associated with Parkinson’s. The most well-known mutations affect the SNCA, LRRK2, and GBA genes, among others. In total, nine genetic mutations have been closely linked to an increased risk of Parkinson’s, with some having a more direct impact on early-onset forms of the disease.

​

- SNCA Gene: This gene provides instructions for making alpha-synuclein, a protein that, when it builds up abnormally, forms clumps called Lewy bodies in the brain—a hallmark of Parkinson’s disease.

​

- LRRK2 Gene: Mutations in this gene are the most common cause of familial Parkinson’s, especially in certain populations. LRRK2 mutations are associated with disruptions in cell signaling pathways, leading to neuronal death.

​

- GBA Gene: Mutations in the GBA gene, which is involved in breaking down fats in the body, have been found in people with Parkinson’s. These mutations are also linked to an increased risk of developing Parkinson’s at an earlier age.

​

How Genetics Influence Parkinson’s Disease

While inheriting a mutation in one of these genes does not guarantee that a person will develop Parkinson’s disease, it does increase their susceptibility. In some cases, these mutations directly disrupt the function of proteins that are essential for neuron health, leading to the gradual loss of dopamine-producing cells in the brain’s substantia nigra.

​

For most people, genetics likely interact with environmental factors, such as toxin exposure or lifestyle habits, to increase the overall risk of developing Parkinson’s. The combination of these genetic and environmental factors determines the likelihood of the disease manifesting.

​

Genetic Testing for Parkinson’s Disease

The National Human Genome Research Institute (NHGRI), a division of the National Institutes of Health (NIH), has compiled a vast amount of information on the role of genetics in Parkinson’s disease. Genetic testing can provide valuable insights for individuals who may be at higher risk due to family history or the presence of known genetic mutations. For some, this knowledge can offer early warning signs, allowing them to adopt preventive strategies before symptoms appear.

​

Managing Genetic Risk Through Lifestyle and Nutrition

While genetic factors can increase the risk of Parkinson’s, there are proactive steps that individuals can take to potentially reduce their risk or slow the disease’s progression. Those found to have one or more genetic mutations linked to Parkinson’s, as well as those with a family history of the disease, can benefit from adopting neuroprotective strategies.

​

- Nutritional Approaches: A diet rich in antioxidants, such as vitamin E, vitamin C, and omega-3 fatty acids, may help combat oxidative stress, a significant contributor to neurodegeneration. Additionally, avoiding processed foods and reducing toxin exposure can lessen the overall strain on brain health. 

​

- Physical Exercise: Regular physical activity has been shown to improve motor symptoms and delay disease progression in Parkinson’s. Exercise promotes brain plasticity and helps maintain the health of neurons, including dopamine-producing cells.

​

 - Stress Management: Managing stress through techniques such as mindfulness, yoga, or meditation can help reduce inflammation and protect brain function.

​

For those at genetic risk, early intervention with lifestyle changes and nutritional support may help preserve brain health and potentially delay the onset of symptoms. Understanding the genetic underpinnings of Parkinson’s disease opens the door to personalized approaches to prevention and treatment, offering hope for those with a family history of the condition.

​

​

​